The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drug, School of Pharmacy, Anhui Medical University, No. 81 Meishan Road, Hefei 230032, Anhui, China.
First affiliated hospital of Anhui Medical University, Hefei city, Anhui province, People's Republic of China.
Toxicol Lett. 2019 Oct 10;314:89-97. doi: 10.1016/j.toxlet.2019.07.021. Epub 2019 Jul 17.
Ethanol is a key factor in the pathogenesis of alcoholic liver disease (ALD), commonly characterized as liver inflammation. Recently, circular (circ)RNAs have emerged as important targets to cure liver diseases. However, there are no studies investigating the role of circ_1639 in reducing inflammatory responses in ALD. In this study, we found that circ_1639 was upregulated in Kupffer cells from the livers of alcohol fed mice. We hypothesized that circ_1639 inhibition is a potential novel therapy for treating ALD. To test this hypothesis, RAW 264.7 cells were treated with ethanol and transfected with circ_1639 overexpression or knockdown plasmids. We present western blotting, qRT-PCR, and ELISA data that suggest that circ_1639 is a proinflammatory factor in the liver and is involved in the activation of the NF-κB signaling pathway. Using luciferase reporter assay, we confirmed that microRNA (miR)-122 is a target gene of circ_1639. We also show that TNFRSF13C is a key regulator of RAW 264.7 cell activation, and acts as a downstream target for miR-122. In summary, our results suggest that inhibition of circ_1639 expression may reduce inflammatory responses in ALD.
乙醇是酒精性肝病 (ALD) 发病机制中的一个关键因素,通常表现为肝脏炎症。最近,环状 (circ)RNAs 已成为治疗肝脏疾病的重要靶点。然而,目前还没有研究调查 circ_1639 在减轻 ALD 炎症反应中的作用。在本研究中,我们发现 circ_1639 在酒精喂养小鼠肝脏的枯否细胞中上调。我们假设抑制 circ_1639 是治疗 ALD 的一种潜在新疗法。为了验证这一假设,我们用乙醇处理 RAW 264.7 细胞,并转染 circ_1639 过表达或敲低质粒。我们提供了 Western blot、qRT-PCR 和 ELISA 数据,表明 circ_1639 是肝脏中的促炎因子,并参与 NF-κB 信号通路的激活。通过荧光素酶报告基因检测,我们证实了 microRNA (miR)-122 是 circ_1639 的靶基因。我们还表明 TNFRSF13C 是 RAW 264.7 细胞激活的关键调节剂,并且作为 miR-122 的下游靶标。总之,我们的结果表明抑制 circ_1639 的表达可能会减轻 ALD 中的炎症反应。